Authors
Latest:
FDA Advisory Committee Vote Unanimous on Harmonizing COVID Vaccine FormulationsThe FDA and CDC must adopt the VRBPAC recommendation before it can be considered for implementation.
Latest:
Expert Perspectives 2024: Breakthrough Therapy for Congenital Adrenal Hyperplasia with PI Richard Auchus, MD, PhDThe lead investigator of the largest clinical trial program in people with CAH discusses the condition, its burden, and the novel drug just approved that will change lives.
Latest:
Key Insights and Practical Tips: Wisdom from UCSD Practitioners for Effective T1D ManagementThe panel of experts from UCSD concludes the discussion on delaying the onset of stage 3 T1D by providing key takeaways and clinical advice on the treatment of patients with this condition.
Latest:
Role of Bempedoic Acid in Clinical PracticeExperts discuss key takeaways from the review article “Role of Bempedoic Acid in Clinical Practice”, clinical implications, and the greatly anticipated CLEAR Outcomes trial.
Latest:
CDC Updates HCV Screening Guidelines to Increase Linkage to CareThe CDC update recommends ending screening strategies that require multiple clinic visits for sample collection, favoring 1 visit and automatic HCV RNA testing.
Latest:
ACIP 2023 Vaccination Schedule Update, At-a-GlanceAmong the CDC vaccine advisory group's recommendations are adding COVID-19 vaccines to the Vaccine for Children program and allowing PCV20 shots for those who previously received PCV13.
Latest:
Social Determinants of Obesity: Treating Urban & Rural PatientsSocial determinants of health vary between patients living in different environments, so what are the key factors to consider when creating a treatment plan?
Latest:
Moderna launches COVID booster campaignThe “Do It For You & Them” campaign focuses on the impact that virus has on day-to-day lives.
Latest:
Novel Weight Loss Entrant from Amgen Challenges Duration of Effect and Dosing with Wegovy, ZepboundAmgen's investigational maridebart cafraglutide in a phase 1 trial led to durable weight reduction following less frequent and lower doses, the company said.
Latest:
Key Takeaways for the Management of MDDCarmen Kosicek, MSN, PMHNP-BC; Charles Montano, MD; and Gus Alva, MD, DFAPA, provide take-home messages for the management of patients with MDD and other depressive disorders.
Latest:
Sleep & Obesity: How to Prescribe Better Sleep for PatientsEducating patients with obesity about the link between poor sleep and weight gain is crucial. Review 5 key elements for achieving better sleep, here.
Latest:
Conversations Around Pediatric Obesity: Communicating with CompassionWeight management in children and adolescents with obesity requires unique sensitivity to the physical and emotional needs of these vulnerable pediatric patients.
Latest:
Key Final Takeaways on Treating Elderly Patients With HypothyroidismAlex Tessnow, MD, concludes this series with key final takeaways.
Latest:
Key Takeaways and Practice Pearls from Leading KOLs on Diabetes Management in Older AdultsThe medical experts conclude by summarizing essential insights and practical tips for effectively managing diabetes in elderly patients.
Latest:
The Most Common Bleeding Disorder in Your Patients Could be Hiding in Plain Sightvon Willebrand disease affects up to 1% of the population yet diagnosis is delayed an average of 16 years after onset of symptoms, especially in women.
Latest:
Practice Pearls for Optimizing MDD TreatmentGreg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, provide their practice pearls for community psychiatrists and psychiatric nurse practitioners who care for patients with major depressive disorder (MDD) to optimize their treatment and management.
Latest:
Helping Patients with Obesity Age Healthier and HappierThree diets that can help patients with obesity age healthier, how to make nutrition personal, and more highlighted, here.
Latest:
Closing Thoughts on the Treatment of MDDRoger S. McIntyre, MD, FRCPC, and Carmen Kosicek, MSN, PMHNP-BC, discuss the future of MDD treatment and share closing thoughts.
Latest:
Patient Selection for Teplizumab and Infusion ProcessPanelists discuss how patient selection for teplizumab therapy requires careful screening for autoantibody positivity and preserved C-peptide function, followed by a 14-day outpatient infusion process that needs close monitoring for cytokine release syndrome and other potential adverse effects.
Latest:
Final Thoughts on Identifying and Managing Patients with T1DPanelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.
Latest:
Refining Diabetes Care for Older Adults: Expert Insights on Deprescribing, Streamlining Treatment, and Key Practice PearlsExperts on diabetes provide insights gleaned from the SIMPLE study and outline patient factors that inform treatment decisions.
Latest:
Key Insights and Final Thoughts on Screening and Management of T1DPanelists discuss key insights on the importance of early screening for T1D, the role of antibody testing in identifying at-risk individuals, and the need for timely intervention to preserve ß-cell function and optimize long-term management strategies for better patient outcomes.
Latest:
FDA's First Draft Guidance on Clinical Trials with Psychedelic Drugs Now Available for CommentThe FDA's recommendations serve to inform potential research sponsors on development protocols for psychedelics and to solicit comment from industry.
Latest:
Tips for Safe Post-Pandemic Telehealth UseBeware the potential pitfalls of telemedicine, from privacy concerns to patient confusion, says associate general counsel for The Doctors Company.
Latest:
Clinical Implications of Off Target TSH Levels and Importance of Patient Education in Managing HypothyroidismEndocrinology experts discuss the clinical implications of off-target TSH levels and stress the importance of stabilizing these levels for hypothyroidism management.
Latest:
CDC Endorses GSK, Pfizer RSV Vaccines for Older AdultsThe 2 new vaccines are authorized for adults aged 60 years and older and with CDC Director Walensky's final nod, should be available this fall.
Latest:
Key Takeaways for the Management of MDDCarmen Kosicek, MSN, PMHNP-BC; Charles Montano, MD; and Gus Alva, MD, DFAPA, provide take-home messages for the management of patients with MDD and other depressive disorders.
Latest:
Key Insights and Practical Tips: Wisdom from UCSD Practitioners for Effective T1D ManagementThe panel of experts from UCSD concludes the discussion on delaying the onset of stage 3 T1D by providing key takeaways and clinical advice on the treatment of patients with this condition.
